The L162V polymorphism at the peroxisome proliferator activated receptor alpha locus modulates the risk of cardiovascular events associated with insulin resistance and diabetes mellitus: the Veterans Affairs HDL Intervention Trial (VA-HIT).
about
A reexamination of the PPAR-alpha activation mode of action as a basis for assessing human cancer risks of environmental contaminants.The genetics of vascular complications in diabetes mellitus.Gene-Gene Interactions among Pparα/δ/γ Polymorphisms for Apolipoprotein (Apo) A-I/Apob Ratio in Chinese Han PopulationRare PPARA variants and extreme response to fenofibrate in the Genetics of Lipid-Lowering Drugs and Diet Network Study.The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects.PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease.Pharmacogenetics of the PPAR genes and cardiovascular disease.Polymorphisms in the peroxisome proliferator activated receptor alpha gene are associated with levels of apolipoprotein CIII and triglyceride in African-Americans but not Caucasians.Peroxisome proliferator-activated receptor-alpha (PPARA) genetic polymorphisms and breast cancer risk: a Long Island ancillary studyPPAR-α as a key nutritional and environmental sensor for metabolic adaptation.Pharmacogenomics of high-density lipoprotein-cholesterol-raising therapies.
P2860
Q33569334-C9E7E104-8F7C-4BFC-9910-C59160DA7A01Q33995879-E52B0E35-7A75-44E0-B7D0-157BD00D3615Q35763261-2AB52F05-EB19-4953-AEDA-63FC8B7FB07BQ35886146-E39BDD2D-DE01-4FAC-A4ED-A0A66342B19EQ36445381-0EFD8638-982C-4862-BBC7-CDC6E35F1BF4Q36528512-172180D1-3A12-4786-8001-CDEF87D08BD2Q37012017-271AFD6C-1930-4420-B907-C4C83B3616C5Q37184082-0227D87C-6ABC-4F93-B37A-4D347ED55A1DQ37294649-BA8789AC-D4E6-497F-BE4C-984EC8C1D4BFQ37616202-56FC6F74-EFAD-4D4A-87C4-1B572F5060BEQ37695401-7719AE85-0A7C-43A2-BA1A-680F37ED55CF
P2860
The L162V polymorphism at the peroxisome proliferator activated receptor alpha locus modulates the risk of cardiovascular events associated with insulin resistance and diabetes mellitus: the Veterans Affairs HDL Intervention Trial (VA-HIT).
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
The L162V polymorphism at the ...... L Intervention Trial (VA-HIT).
@en
The L162V polymorphism at the ...... Affairs HDL Intervention Trial
@nl
type
label
The L162V polymorphism at the ...... L Intervention Trial (VA-HIT).
@en
The L162V polymorphism at the ...... Affairs HDL Intervention Trial
@nl
prefLabel
The L162V polymorphism at the ...... L Intervention Trial (VA-HIT).
@en
The L162V polymorphism at the ...... Affairs HDL Intervention Trial
@nl
P2093
P50
P1433
P1476
The L162V polymorphism at the ...... L Intervention Trial (VA-HIT).
@en
P2093
Dorothea Collins
Ernst J Schaefer
John J O'Connor
Margaret E Brousseau
P304
P356
10.1016/J.ATHEROSCLEROSIS.2005.08.034
P577
2005-10-10T00:00:00Z